Rank | Gene Set | Z-score |
---|---|---|
1 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.94938989 |
2 | regulation of interferon-alpha production (GO:0032647) | 4.76301514 |
3 | DNA strand elongation (GO:0022616) | 4.70917236 |
4 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.60048572 |
5 | positive regulation of interferon-alpha production (GO:0032727) | 4.58805325 |
6 | response to peptidoglycan (GO:0032494) | 4.53458699 |
7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.46087379 |
8 | maturation of SSU-rRNA (GO:0030490) | 4.30857965 |
9 | telomere maintenance via recombination (GO:0000722) | 4.27044073 |
10 | ribosomal small subunit assembly (GO:0000028) | 4.14946297 |
11 | DNA replication initiation (GO:0006270) | 4.13788352 |
12 | mitotic recombination (GO:0006312) | 4.05637165 |
13 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.99183982 |
14 | DNA deamination (GO:0045006) | 3.98947595 |
15 | chromatin remodeling at centromere (GO:0031055) | 3.95077321 |
16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.94505055 |
17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.92123570 |
18 | CENP-A containing nucleosome assembly (GO:0034080) | 3.84431036 |
19 | negative regulation of interleukin-12 production (GO:0032695) | 3.78308312 |
20 | DNA replication checkpoint (GO:0000076) | 3.72958187 |
21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72885201 |
22 | nucleobase biosynthetic process (GO:0046112) | 3.72863431 |
23 | nuclear pore organization (GO:0006999) | 3.70779024 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.68308073 |
25 | positive regulation of interferon-beta production (GO:0032728) | 3.67759139 |
26 | kinetochore organization (GO:0051383) | 3.67340382 |
27 | formation of translation preinitiation complex (GO:0001731) | 3.59385049 |
28 | purine nucleobase biosynthetic process (GO:0009113) | 3.56943498 |
29 | nuclear pore complex assembly (GO:0051292) | 3.55986744 |
30 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.54063439 |
31 | cellular response to interferon-alpha (GO:0035457) | 3.53148458 |
32 | telomere maintenance via telomere lengthening (GO:0010833) | 3.52723190 |
33 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.52354409 |
34 | mitotic metaphase plate congression (GO:0007080) | 3.48603937 |
35 | cellular response to type I interferon (GO:0071357) | 3.48056576 |
36 | type I interferon signaling pathway (GO:0060337) | 3.48056576 |
37 | neutrophil activation involved in immune response (GO:0002283) | 3.45475714 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.44045000 |
39 | modulation by symbiont of host defense response (GO:0052031) | 3.44045000 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.44045000 |
41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.44045000 |
42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.44045000 |
43 | modulation by symbiont of host immune response (GO:0052553) | 3.44045000 |
44 | IMP biosynthetic process (GO:0006188) | 3.42958621 |
45 | response to type I interferon (GO:0034340) | 3.40867083 |
46 | detection of molecule of bacterial origin (GO:0032490) | 3.40732776 |
47 | ribosomal large subunit biogenesis (GO:0042273) | 3.39265452 |
48 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.38991657 |
49 | DNA replication-independent nucleosome organization (GO:0034724) | 3.38991657 |
50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38934143 |
51 | T-helper 1 type immune response (GO:0042088) | 3.31495456 |
52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.27462642 |
53 | mitotic nuclear envelope disassembly (GO:0007077) | 3.26868573 |
54 | macrophage activation involved in immune response (GO:0002281) | 3.25431552 |
55 | metaphase plate congression (GO:0051310) | 3.22373197 |
56 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.18749162 |
57 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.18749162 |
58 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.15550994 |
59 | regulation of vitamin metabolic process (GO:0030656) | 3.15120945 |
60 | response to interferon-alpha (GO:0035455) | 3.14062023 |
61 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.13462603 |
62 | translational termination (GO:0006415) | 3.13032868 |
63 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.11496345 |
64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10438346 |
65 | viral transcription (GO:0019083) | 3.10023066 |
66 | kinetochore assembly (GO:0051382) | 3.08721520 |
67 | histone exchange (GO:0043486) | 3.08616387 |
68 | mitotic chromosome condensation (GO:0007076) | 3.08201135 |
69 | protein localization to kinetochore (GO:0034501) | 3.07647352 |
70 | IMP metabolic process (GO:0046040) | 3.06356500 |
71 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.04768735 |
72 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.04277849 |
73 | ribosomal small subunit biogenesis (GO:0042274) | 3.03428820 |
74 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.01057188 |
75 | nuclear envelope disassembly (GO:0051081) | 2.98841995 |
76 | membrane disassembly (GO:0030397) | 2.98841995 |
77 | regulation of response to interferon-gamma (GO:0060330) | 2.98371644 |
78 | hepatocyte apoptotic process (GO:0097284) | 2.97601861 |
79 | * DNA geometric change (GO:0032392) | 2.96927898 |
80 | * DNA duplex unwinding (GO:0032508) | 2.96249648 |
81 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.96211645 |
82 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95430782 |
83 | establishment of chromosome localization (GO:0051303) | 2.95401945 |
84 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.95213738 |
85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94536930 |
86 | ribosome biogenesis (GO:0042254) | 2.93849463 |
87 | translational elongation (GO:0006414) | 2.91707271 |
88 | B cell mediated immunity (GO:0019724) | 2.91645710 |
89 | * telomere maintenance (GO:0000723) | 2.89658958 |
90 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.88639413 |
91 | negative regulation of viral genome replication (GO:0045071) | 2.88500267 |
92 | mitotic sister chromatid cohesion (GO:0007064) | 2.88009073 |
93 | * telomere organization (GO:0032200) | 2.87269409 |
94 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.87017778 |
95 | regulation of interferon-beta production (GO:0032648) | 2.86566863 |
96 | immunoglobulin mediated immune response (GO:0016064) | 2.86316642 |
97 | cotranslational protein targeting to membrane (GO:0006613) | 2.84779580 |
98 | positive regulation of type 2 immune response (GO:0002830) | 2.84218654 |
99 | protein targeting to ER (GO:0045047) | 2.83975634 |
100 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83435624 |
101 | response to host immune response (GO:0052572) | 2.83435624 |
102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82394541 |
103 | pore complex assembly (GO:0046931) | 2.82118920 |
104 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.82086719 |
105 | protein localization to chromosome, centromeric region (GO:0071459) | 2.81906735 |
106 | necroptotic process (GO:0070266) | 2.79004504 |
107 | translesion synthesis (GO:0019985) | 2.76621067 |
108 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.76509582 |
109 | translational initiation (GO:0006413) | 2.75550278 |
110 | rRNA processing (GO:0006364) | 2.74954289 |
111 | intra-S DNA damage checkpoint (GO:0031573) | 2.74177498 |
112 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73733613 |
113 | regulation of interleukin-12 production (GO:0032655) | 2.73045620 |
114 | cellular response to ethanol (GO:0071361) | 2.71964752 |
115 | germinal center formation (GO:0002467) | 2.71704192 |
116 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.71556214 |
117 | regulation of podosome assembly (GO:0071801) | 2.70968187 |
118 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.70523326 |
119 | histone-serine phosphorylation (GO:0035404) | 2.69325224 |
120 | positive regulation of interleukin-12 production (GO:0032735) | 2.69103330 |
121 | meiotic chromosome segregation (GO:0045132) | 2.68711203 |
122 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.67250682 |
123 | establishment of integrated proviral latency (GO:0075713) | 2.66454423 |
124 | protein localization to endoplasmic reticulum (GO:0070972) | 2.65004064 |
125 | postreplication repair (GO:0006301) | 2.64971210 |
126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64267584 |
127 | regulation of chronic inflammatory response (GO:0002676) | 2.63536332 |
128 | response to protozoan (GO:0001562) | 2.63347438 |
129 | response to host (GO:0075136) | 2.63321741 |
130 | response to host defenses (GO:0052200) | 2.63321741 |
131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63321741 |
132 | rRNA metabolic process (GO:0016072) | 2.63121107 |
133 | chromatin assembly or disassembly (GO:0006333) | 2.62715391 |
134 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.61693010 |
135 | defense response to protozoan (GO:0042832) | 2.61626005 |
136 | positive regulation of interleukin-6 production (GO:0032755) | 2.61387202 |
137 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.61300613 |
138 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.59930388 |
139 | regulation of fever generation (GO:0031620) | 2.59794405 |
140 | regulation of chemokine biosynthetic process (GO:0045073) | 2.58675258 |
141 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.58062125 |
142 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.57167015 |
143 | mitotic sister chromatid segregation (GO:0000070) | 2.56983811 |
144 | folic acid metabolic process (GO:0046655) | 2.56741947 |
145 | regulation of T-helper cell differentiation (GO:0045622) | 2.56700695 |
146 | positive regulation of interleukin-10 production (GO:0032733) | 2.56202145 |
147 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.56182043 |
148 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.55400945 |
149 | spliceosomal snRNP assembly (GO:0000387) | 2.55332423 |
150 | granulocyte activation (GO:0036230) | 2.55236598 |
151 | tetrahydrofolate metabolic process (GO:0046653) | 2.54002723 |
152 | T cell migration (GO:0072678) | 2.53895823 |
153 | cellular response to lipopolysaccharide (GO:0071222) | 2.53714482 |
154 | response to muramyl dipeptide (GO:0032495) | 2.53416214 |
155 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.52447000 |
156 | ribosome assembly (GO:0042255) | 2.51896182 |
157 | DNA double-strand break processing (GO:0000729) | 2.51753424 |
158 | cellular response to molecule of bacterial origin (GO:0071219) | 2.51164215 |
159 | negative regulation of growth of symbiont in host (GO:0044130) | 2.50651599 |
160 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.50651599 |
161 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.50651599 |
162 | regulation of growth of symbiont in host (GO:0044126) | 2.50651599 |
163 | regulation of helicase activity (GO:0051095) | 2.50432605 |
164 | cell cycle G1/S phase transition (GO:0044843) | 2.50385610 |
165 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.50385610 |
166 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.49557467 |
167 | * somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.49537694 |
168 | * somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.49537694 |
169 | * isotype switching (GO:0045190) | 2.49537694 |
170 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.49461067 |
171 | * DNA conformation change (GO:0071103) | 2.48868372 |
172 | myeloid dendritic cell activation (GO:0001773) | 2.48289274 |
173 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.48267273 |
174 | mismatch repair (GO:0006298) | 2.48001061 |
175 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.47993724 |
176 | pseudouridine synthesis (GO:0001522) | 2.47272568 |
177 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47110100 |
178 | sister chromatid segregation (GO:0000819) | 2.46624559 |
179 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.46563392 |
180 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.46563392 |
181 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.46563392 |
182 | negative regulation of sister chromatid segregation (GO:0033046) | 2.46563392 |
183 | spindle assembly checkpoint (GO:0071173) | 2.46549730 |
184 | DNA replication (GO:0006260) | 2.46419326 |
185 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.45849494 |
186 | neutrophil activation (GO:0042119) | 2.44752028 |
187 | response to dsRNA (GO:0043331) | 2.44362000 |
188 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.43795511 |
189 | negative regulation of chromosome segregation (GO:0051985) | 2.43316838 |
190 | cellular component biogenesis (GO:0044085) | 2.42808172 |
191 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.42518936 |
192 | NIK/NF-kappaB signaling (GO:0038061) | 2.42380646 |
193 | defense response to virus (GO:0051607) | 2.42098379 |
194 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.41574442 |
195 | regulation of RIG-I signaling pathway (GO:0039535) | 2.41456085 |
196 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.41348293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.01717776 |
2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.92546731 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60884891 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49339053 |
5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.45359978 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35277706 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.25979064 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.22197342 |
9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.87206468 |
10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.81254432 |
11 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72249691 |
12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.71470207 |
13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.66205646 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47040308 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.46002734 |
16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.45955817 |
17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.43984925 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43763424 |
19 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42278926 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.40942745 |
21 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.37178636 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36153447 |
23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33274986 |
24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32602849 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27331217 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26098246 |
27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.17211996 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16101101 |
29 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.15056788 |
30 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05244242 |
31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.05127729 |
32 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.04383932 |
33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04345450 |
34 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03566819 |
35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94739595 |
36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94353691 |
37 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92028993 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91814283 |
39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.91394974 |
40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89714281 |
41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88117865 |
42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83775358 |
43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82483725 |
44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.70058211 |
45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69504154 |
46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.65642435 |
47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63124720 |
48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62952161 |
49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61553792 |
50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.60808177 |
51 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.60625166 |
52 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58545449 |
53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58251230 |
54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55513049 |
55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54784395 |
56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54283938 |
57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.53695719 |
58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.51795636 |
59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51429085 |
60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47936917 |
61 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.47916584 |
62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.47102697 |
63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43907360 |
64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.42060773 |
65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40786958 |
66 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40645270 |
67 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.40356151 |
68 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38182260 |
69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37943244 |
70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.36643667 |
71 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35973716 |
72 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.35699706 |
73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35589636 |
74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33433577 |
75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31513333 |
76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30971215 |
77 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29600961 |
78 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28742372 |
79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28378581 |
80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27549554 |
81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.27014326 |
82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26276133 |
83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25543240 |
84 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.25485806 |
85 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25214417 |
86 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23076152 |
87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20235240 |
88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19830418 |
89 | MYC_22102868_ChIP-Seq_BL_Human | 1.19564403 |
90 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.18906740 |
91 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.18349283 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16633161 |
93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16284326 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16186099 |
95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15993970 |
96 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14355161 |
97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13213900 |
98 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11181836 |
99 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10412952 |
100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09821265 |
101 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09358374 |
102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04047517 |
103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04047517 |
104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03654250 |
105 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02994357 |
106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02980144 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02288073 |
108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02089685 |
109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01080031 |
110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99429954 |
111 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98088365 |
112 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96226402 |
113 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95899804 |
114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95544933 |
115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94713263 |
116 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94333703 |
117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93916587 |
118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93333580 |
119 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93168421 |
120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93151819 |
121 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92898948 |
122 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90958331 |
123 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90740601 |
124 | MAF_26560356_Chip-Seq_TH1_Human | 0.89887066 |
125 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89839218 |
126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.89493177 |
127 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89398423 |
128 | MYB_26560356_Chip-Seq_TH1_Human | 0.87774445 |
129 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87605678 |
130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87548317 |
131 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87465316 |
132 | MYB_26560356_Chip-Seq_TH2_Human | 0.86806425 |
133 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86641520 |
134 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.86077925 |
135 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85876599 |
136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85341417 |
137 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84942128 |
138 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84916351 |
139 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84537327 |
140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84527630 |
141 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.83891353 |
142 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82801801 |
143 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.81932074 |
144 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81448911 |
145 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.81421639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.33566593 |
2 | MP0003693_abnormal_embryo_hatching | 4.04143298 |
3 | * MP0010094_abnormal_chromosome_stability | 3.66054345 |
4 | * MP0004957_abnormal_blastocyst_morpholog | 3.23201369 |
5 | MP0008057_abnormal_DNA_replication | 3.16642337 |
6 | MP0003111_abnormal_nucleus_morphology | 2.87228641 |
7 | * MP0003077_abnormal_cell_cycle | 2.85654168 |
8 | MP0008058_abnormal_DNA_repair | 2.51986539 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.45279227 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.41835547 |
11 | MP0002396_abnormal_hematopoietic_system | 2.39137657 |
12 | MP0008007_abnormal_cellular_replicative | 2.33965523 |
13 | MP0005451_abnormal_body_composition | 2.30523448 |
14 | MP0006082_CNS_inflammation | 2.24616241 |
15 | MP0006054_spinal_hemorrhage | 2.10121554 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.07733737 |
17 | MP0003300_gastrointestinal_ulcer | 1.95660257 |
18 | MP0002419_abnormal_innate_immunity | 1.93585354 |
19 | MP0003186_abnormal_redox_activity | 1.80937116 |
20 | MP0004808_abnormal_hematopoietic_stem | 1.79939108 |
21 | MP0001835_abnormal_antigen_presentation | 1.77522878 |
22 | MP0010352_gastrointestinal_tract_polyps | 1.75113356 |
23 | MP0005387_immune_system_phenotype | 1.74270701 |
24 | MP0001790_abnormal_immune_system | 1.74270701 |
25 | MP0002877_abnormal_melanocyte_morpholog | 1.71685146 |
26 | * MP0008932_abnormal_embryonic_tissue | 1.71673210 |
27 | MP0009697_abnormal_copulation | 1.63300353 |
28 | MP0004947_skin_inflammation | 1.63117495 |
29 | MP0003123_paternal_imprinting | 1.60935269 |
30 | MP0003786_premature_aging | 1.58732159 |
31 | MP0009764_decreased_sensitivity_to | 1.56668115 |
32 | MP0000490_abnormal_crypts_of | 1.54959554 |
33 | MP0003763_abnormal_thymus_physiology | 1.53625221 |
34 | MP0001730_embryonic_growth_arrest | 1.51889975 |
35 | MP0008877_abnormal_DNA_methylation | 1.51300179 |
36 | MP0001545_abnormal_hematopoietic_system | 1.50406154 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.50406154 |
38 | * MP0000350_abnormal_cell_proliferation | 1.49353480 |
39 | MP0003448_altered_tumor_morphology | 1.47959752 |
40 | MP0009785_altered_susceptibility_to | 1.41927629 |
41 | MP0009840_abnormal_foam_cell | 1.41242570 |
42 | MP0008260_abnormal_autophagy | 1.41239023 |
43 | MP0001853_heart_inflammation | 1.41086321 |
44 | MP0002332_abnormal_exercise_endurance | 1.37965884 |
45 | MP0000569_abnormal_digit_pigmentation | 1.32955263 |
46 | MP0010234_abnormal_vibrissa_follicle | 1.31633214 |
47 | * MP0010307_abnormal_tumor_latency | 1.31100145 |
48 | MP0003453_abnormal_keratinocyte_physiol | 1.28376581 |
49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27794370 |
50 | MP0002139_abnormal_hepatobiliary_system | 1.27225951 |
51 | * MP0002019_abnormal_tumor_incidence | 1.26085038 |
52 | MP0005310_abnormal_salivary_gland | 1.23040341 |
53 | * MP0002398_abnormal_bone_marrow | 1.22295463 |
54 | MP0003183_abnormal_peptide_metabolism | 1.22104386 |
55 | MP0005058_abnormal_lysosome_morphology | 1.19670104 |
56 | * MP0000313_abnormal_cell_death | 1.18314961 |
57 | MP0003075_altered_response_to | 1.17836381 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.15937201 |
59 | MP0001533_abnormal_skeleton_physiology | 1.15594622 |
60 | MP0006036_abnormal_mitochondrial_physio | 1.14692281 |
61 | MP0002166_altered_tumor_susceptibility | 1.14610551 |
62 | MP0000689_abnormal_spleen_morphology | 1.14506841 |
63 | * MP0005380_embryogenesis_phenotype | 1.12694752 |
64 | * MP0001672_abnormal_embryogenesis/_devel | 1.12694752 |
65 | MP0000685_abnormal_immune_system | 1.11871759 |
66 | * MP0003984_embryonic_growth_retardation | 1.11668584 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.09969894 |
68 | MP0005464_abnormal_platelet_physiology | 1.09953036 |
69 | MP0003941_abnormal_skin_development | 1.09636297 |
70 | MP0003943_abnormal_hepatobiliary_system | 1.08865938 |
71 | MP0008004_abnormal_stomach_pH | 1.08591025 |
72 | MP0003705_abnormal_hypodermis_morpholog | 1.08434193 |
73 | * MP0002088_abnormal_embryonic_growth/wei | 1.08361571 |
74 | * MP0002722_abnormal_immune_system | 1.07668930 |
75 | * MP0001697_abnormal_embryo_size | 1.06779610 |
76 | MP0003567_abnormal_fetal_cardiomyocyte | 1.05151122 |
77 | MP0005360_urolithiasis | 1.05143247 |
78 | MP0004147_increased_porphyrin_level | 1.04882664 |
79 | MP0003091_abnormal_cell_migration | 1.04323568 |
80 | * MP0002080_prenatal_lethality | 1.02647961 |
81 | * MP0000703_abnormal_thymus_morphology | 1.01280698 |
82 | MP0009379_abnormal_foot_pigmentation | 1.00510934 |
83 | MP0002006_tumorigenesis | 1.00438164 |
84 | * MP0002429_abnormal_blood_cell | 1.00321605 |
85 | MP0004185_abnormal_adipocyte_glucose | 0.98885878 |
86 | MP0005164_abnormal_response_to | 0.98286288 |
87 | MP0010030_abnormal_orbit_morphology | 0.97359967 |
88 | MP0005671_abnormal_response_to | 0.96636952 |
89 | * MP0001800_abnormal_humoral_immune | 0.96609222 |
90 | MP0010678_abnormal_skin_adnexa | 0.96012351 |
91 | MP0003656_abnormal_erythrocyte_physiolo | 0.95886304 |
92 | MP0003436_decreased_susceptibility_to | 0.95152167 |
93 | MP0010155_abnormal_intestine_physiology | 0.94525946 |
94 | MP0000598_abnormal_liver_morphology | 0.93766125 |
95 | MP0005621_abnormal_cell_physiology | 0.93734677 |
96 | MP0005365_abnormal_bile_salt | 0.93214098 |
97 | MP0003724_increased_susceptibility_to | 0.91333489 |
98 | * MP0000716_abnormal_immune_system | 0.90974091 |
99 | * MP0002452_abnormal_antigen_presenting | 0.90928042 |
100 | * MP0002086_abnormal_extraembryonic_tissu | 0.90552799 |
101 | MP0004197_abnormal_fetal_growth/weight/ | 0.89351179 |
102 | MP0005166_decreased_susceptibility_to | 0.88933429 |
103 | MP0001764_abnormal_homeostasis | 0.87881990 |
104 | MP0001727_abnormal_embryo_implantation | 0.87638512 |
105 | MP0005085_abnormal_gallbladder_physiolo | 0.85599190 |
106 | * MP0002723_abnormal_immune_serum | 0.84878855 |
107 | MP0005319_abnormal_enzyme/_coenzyme | 0.84028769 |
108 | MP0005076_abnormal_cell_differentiation | 0.83762953 |
109 | * MP0002420_abnormal_adaptive_immunity | 0.83624248 |
110 | MP0004883_abnormal_blood_vessel | 0.83145978 |
111 | MP0004264_abnormal_extraembryonic_tissu | 0.82976321 |
112 | MP0002405_respiratory_system_inflammati | 0.81955114 |
113 | * MP0001819_abnormal_immune_cell | 0.81691854 |
114 | MP0005000_abnormal_immune_tolerance | 0.81518032 |
115 | MP0005023_abnormal_wound_healing | 0.80512895 |
116 | MP0001216_abnormal_epidermal_layer | 0.79603988 |
117 | MP0001873_stomach_inflammation | 0.79454282 |
118 | MP0004510_myositis | 0.79318330 |
119 | MP0005025_abnormal_response_to | 0.78657020 |
120 | MP0000371_diluted_coat_color | 0.78148124 |
121 | MP0003950_abnormal_plasma_membrane | 0.77982539 |
122 | MP0000609_abnormal_liver_physiology | 0.77658537 |
123 | MP0008469_abnormal_protein_level | 0.77016571 |
124 | MP0001191_abnormal_skin_condition | 0.75577859 |
125 | MP0002998_abnormal_bone_remodeling | 0.75247173 |
126 | MP0002009_preneoplasia | 0.74349974 |
127 | * MP0009763_increased_sensitivity_to | 0.74175101 |
128 | MP0001845_abnormal_inflammatory_respons | 0.74088080 |
129 | MP0003718_maternal_effect | 0.72631636 |
130 | MP0000858_altered_metastatic_potential | 0.69851429 |
131 | MP0005408_hypopigmentation | 0.68081898 |
132 | MP0000358_abnormal_cell_content/ | 0.66616228 |
133 | MP0000343_altered_response_to | 0.65325754 |
134 | MP0005083_abnormal_biliary_tract | 0.64964324 |
135 | MP0002084_abnormal_developmental_patter | 0.63909531 |
136 | MP0009278_abnormal_bone_marrow | 0.63202885 |
137 | MP0004084_abnormal_cardiac_muscle | 0.63041918 |
138 | MP0003566_abnormal_cell_adhesion | 0.62519536 |
139 | * MP0002085_abnormal_embryonic_tissue | 0.62225288 |
140 | MP0003121_genomic_imprinting | 0.61511333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent bacterial skin infections (HP:0005406) | 4.07733045 |
2 | Recurrent abscess formation (HP:0002722) | 3.84660043 |
3 | Reticulocytopenia (HP:0001896) | 3.81747712 |
4 | Abnormal number of erythroid precursors (HP:0012131) | 3.77967427 |
5 | Retrobulbar optic neuritis (HP:0100654) | 3.76385858 |
6 | Optic neuritis (HP:0100653) | 3.76385858 |
7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.65939349 |
8 | Orchitis (HP:0100796) | 3.46237079 |
9 | Recurrent viral infections (HP:0004429) | 3.41683138 |
10 | Subacute progressive viral hepatitis (HP:0006572) | 3.37803187 |
11 | Abnormality of the anterior horn cell (HP:0006802) | 3.37696386 |
12 | Degeneration of anterior horn cells (HP:0002398) | 3.37696386 |
13 | Eczematoid dermatitis (HP:0000976) | 3.31376488 |
14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.27630274 |
15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.27630274 |
16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.27630274 |
17 | Papillary thyroid carcinoma (HP:0002895) | 3.26166415 |
18 | Thrombocytosis (HP:0001894) | 3.10916823 |
19 | Keratoconjunctivitis sicca (HP:0001097) | 3.04833228 |
20 | Birth length less than 3rd percentile (HP:0003561) | 3.04208766 |
21 | Mediastinal lymphadenopathy (HP:0100721) | 3.03752408 |
22 | Viral hepatitis (HP:0006562) | 3.02056736 |
23 | Aplastic anemia (HP:0001915) | 2.99915835 |
24 | Abnormality of macrophages (HP:0004311) | 2.99771424 |
25 | Myositis (HP:0100614) | 2.91897447 |
26 | Micronodular cirrhosis (HP:0001413) | 2.80581848 |
27 | Oral leukoplakia (HP:0002745) | 2.79939644 |
28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79020822 |
29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79020822 |
30 | Disinhibition (HP:0000734) | 2.78251181 |
31 | IgA deficiency (HP:0002720) | 2.76549354 |
32 | Thyroid carcinoma (HP:0002890) | 2.69465695 |
33 | Loss of speech (HP:0002371) | 2.64403385 |
34 | Generalized aminoaciduria (HP:0002909) | 2.64375672 |
35 | Keratoconjunctivitis (HP:0001096) | 2.63784138 |
36 | Colon cancer (HP:0003003) | 2.61640295 |
37 | 11 pairs of ribs (HP:0000878) | 2.61450788 |
38 | Hepatic necrosis (HP:0002605) | 2.57954954 |
39 | Arterial thrombosis (HP:0004420) | 2.56714722 |
40 | Poikiloderma (HP:0001029) | 2.51772628 |
41 | * Abnormality of chromosome stability (HP:0003220) | 2.48457183 |
42 | Stomatitis (HP:0010280) | 2.47085372 |
43 | Pallor (HP:0000980) | 2.45688333 |
44 | Macrocytic anemia (HP:0001972) | 2.45607386 |
45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43726427 |
46 | Nausea (HP:0002018) | 2.42907590 |
47 | Chromsome breakage (HP:0040012) | 2.42140689 |
48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41007182 |
49 | Agnosia (HP:0010524) | 2.40171144 |
50 | Vasculitis (HP:0002633) | 2.39976893 |
51 | Recurrent fungal infections (HP:0002841) | 2.39935572 |
52 | IgM deficiency (HP:0002850) | 2.38378993 |
53 | Colitis (HP:0002583) | 2.37174057 |
54 | Asymmetry of the thorax (HP:0001555) | 2.35853426 |
55 | Autoimmune thrombocytopenia (HP:0001973) | 2.33655400 |
56 | Hypoglycemic coma (HP:0001325) | 2.32550506 |
57 | Gangrene (HP:0100758) | 2.31511407 |
58 | * T lymphocytopenia (HP:0005403) | 2.30583293 |
59 | Entropion (HP:0000621) | 2.28763648 |
60 | Recurrent skin infections (HP:0001581) | 2.28591222 |
61 | Interstitial pulmonary disease (HP:0006530) | 2.27278399 |
62 | Absent frontal sinuses (HP:0002688) | 2.26860351 |
63 | Increased serum lactate (HP:0002151) | 2.26741378 |
64 | Selective tooth agenesis (HP:0001592) | 2.26090941 |
65 | Abnormality of the preputium (HP:0100587) | 2.24296760 |
66 | Abnormality of alanine metabolism (HP:0010916) | 2.23695224 |
67 | Hyperalaninemia (HP:0003348) | 2.23695224 |
68 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.23695224 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23454247 |
70 | Encephalitis (HP:0002383) | 2.22253298 |
71 | * Abnormality of T cell number (HP:0011839) | 2.21869083 |
72 | Renal cortical cysts (HP:0000803) | 2.19938166 |
73 | Hepatocellular necrosis (HP:0001404) | 2.18210366 |
74 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.17928612 |
75 | Increased CSF lactate (HP:0002490) | 2.17811125 |
76 | Type I transferrin isoform profile (HP:0003642) | 2.17091351 |
77 | Curly hair (HP:0002212) | 2.17042095 |
78 | Osteomyelitis (HP:0002754) | 2.16872423 |
79 | Exertional dyspnea (HP:0002875) | 2.16217094 |
80 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.16127500 |
81 | Uterine leiomyosarcoma (HP:0002891) | 2.16011521 |
82 | Leiomyosarcoma (HP:0100243) | 2.16011521 |
83 | Myelodysplasia (HP:0002863) | 2.15104866 |
84 | Meningitis (HP:0001287) | 2.13668725 |
85 | Carpal bone hypoplasia (HP:0001498) | 2.12854755 |
86 | Acute hepatic failure (HP:0006554) | 2.12441761 |
87 | Gastrointestinal infarctions (HP:0005244) | 2.11102777 |
88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.10603527 |
89 | Increased IgM level (HP:0003496) | 2.10578571 |
90 | Fatigue (HP:0012378) | 2.09562141 |
91 | Bladder neoplasm (HP:0009725) | 2.09372642 |
92 | Bladder carcinoma (HP:0002862) | 2.09372642 |
93 | Reduced antithrombin III activity (HP:0001976) | 2.09362196 |
94 | Gingivitis (HP:0000230) | 2.08694667 |
95 | Stomach cancer (HP:0012126) | 2.06745184 |
96 | * Deep philtrum (HP:0002002) | 2.05898306 |
97 | Anorexia (HP:0002039) | 2.05872103 |
98 | Irregular epiphyses (HP:0010582) | 2.05548993 |
99 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.05387701 |
100 | Spinal cord lesions (HP:0100561) | 2.05216075 |
101 | Syringomyelia (HP:0003396) | 2.05216075 |
102 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.04448521 |
103 | Cutaneous melanoma (HP:0012056) | 2.03626398 |
104 | Abnormality of reticulocytes (HP:0004312) | 2.03402139 |
105 | Myocardial infarction (HP:0001658) | 2.03303433 |
106 | Pulmonary infiltrates (HP:0002113) | 2.03133319 |
107 | Cellulitis (HP:0100658) | 2.02698237 |
108 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01039690 |
109 | Insidious onset (HP:0003587) | 2.00883474 |
110 | Termporal pattern (HP:0011008) | 2.00883474 |
111 | Pancytopenia (HP:0001876) | 2.00176566 |
112 | Urticaria (HP:0001025) | 2.00071816 |
113 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99954643 |
114 | Microretrognathia (HP:0000308) | 1.99870233 |
115 | Hypobetalipoproteinemia (HP:0003563) | 1.98946545 |
116 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98677896 |
117 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.98353674 |
118 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97507760 |
119 | Progressive external ophthalmoplegia (HP:0000590) | 1.96786796 |
120 | Meckel diverticulum (HP:0002245) | 1.94531211 |
121 | Periodontitis (HP:0000704) | 1.94483793 |
122 | Basal cell carcinoma (HP:0002671) | 1.93835421 |
123 | Embryonal renal neoplasm (HP:0011794) | 1.93122812 |
124 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.92474485 |
125 | Small intestinal stenosis (HP:0012848) | 1.92085328 |
126 | Duodenal stenosis (HP:0100867) | 1.92085328 |
127 | Acute encephalopathy (HP:0006846) | 1.91287904 |
128 | Prostate neoplasm (HP:0100787) | 1.91263601 |
129 | Premature graying of hair (HP:0002216) | 1.91218645 |
130 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89694422 |
131 | Mitochondrial inheritance (HP:0001427) | 1.89676816 |
132 | Rough bone trabeculation (HP:0100670) | 1.89072756 |
133 | Abnormal protein glycosylation (HP:0012346) | 1.88387621 |
134 | Abnormal glycosylation (HP:0012345) | 1.88387621 |
135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.88387621 |
136 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.88387621 |
137 | Acute necrotizing encephalopathy (HP:0006965) | 1.88357222 |
138 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87284358 |
139 | Abnormal hemoglobin (HP:0011902) | 1.87147581 |
140 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.85925150 |
141 | Granulocytopenia (HP:0001913) | 1.85169487 |
142 | Volvulus (HP:0002580) | 1.84084064 |
143 | Increased muscle lipid content (HP:0009058) | 1.83811495 |
144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83420010 |
145 | Cleft eyelid (HP:0000625) | 1.82874761 |
146 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82845621 |
147 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82845621 |
148 | Vacuolated lymphocytes (HP:0001922) | 1.82627934 |
149 | Osteolytic defects of the hand bones (HP:0009699) | 1.82476535 |
150 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82476535 |
151 | * Autoimmune hemolytic anemia (HP:0001890) | 1.82231983 |
152 | * Medulloblastoma (HP:0002885) | 1.82006416 |
153 | Eosinophilia (HP:0001880) | 1.81358474 |
154 | Abnormality of the ileum (HP:0001549) | 1.80875117 |
155 | Short middle phalanx of the 5th finger (HP:0004220) | 1.80844454 |
156 | Cerebral edema (HP:0002181) | 1.80649439 |
157 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80115961 |
158 | Multiple enchondromatosis (HP:0005701) | 1.79904434 |
159 | Squamous cell carcinoma (HP:0002860) | 1.79371388 |
160 | Neoplasm of head and neck (HP:0012288) | 1.78772877 |
161 | Esophageal neoplasm (HP:0100751) | 1.78772877 |
162 | Chest pain (HP:0100749) | 1.78474623 |
163 | Acute myeloid leukemia (HP:0004808) | 1.78349659 |
164 | Poor head control (HP:0002421) | 1.77508033 |
165 | Leukocytosis (HP:0001974) | 1.77146476 |
166 | Abnormality of T cell physiology (HP:0011840) | 1.76931881 |
167 | Abnormality of serum amino acid levels (HP:0003112) | 1.75660756 |
168 | Absent thumb (HP:0009777) | 1.74209904 |
169 | Gastrointestinal carcinoma (HP:0002672) | 1.74200076 |
170 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.74200076 |
171 | Inflammation of the large intestine (HP:0002037) | 1.73928169 |
172 | Abnormality of the frontal sinuses (HP:0002687) | 1.73614183 |
173 | Abnormal spermatogenesis (HP:0008669) | 1.72960204 |
174 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72215470 |
175 | Dicarboxylic aciduria (HP:0003215) | 1.72215470 |
176 | Impulsivity (HP:0100710) | 1.70913138 |
177 | Lactic acidosis (HP:0003128) | 1.70051586 |
178 | Breast hypoplasia (HP:0003187) | 1.69562493 |
179 | Amaurosis fugax (HP:0100576) | 1.69251472 |
180 | Abnormality of DNA repair (HP:0003254) | 1.68868301 |
181 | * Sloping forehead (HP:0000340) | 1.67358469 |
182 | * Lymphoma (HP:0002665) | 1.67268529 |
183 | Hyperglycinemia (HP:0002154) | 1.67013465 |
184 | IgG deficiency (HP:0004315) | 1.64710958 |
185 | Respiratory difficulties (HP:0002880) | 1.64129015 |
186 | Exercise intolerance (HP:0003546) | 1.63894248 |
187 | Neoplasm of the colon (HP:0100273) | 1.63832173 |
188 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.62654623 |
189 | Abnormality of the duodenum (HP:0002246) | 1.62471949 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDC7 | 3.78194428 |
2 | WEE1 | 3.23483035 |
3 | EIF2AK1 | 3.14991235 |
4 | BRSK2 | 3.12546041 |
5 | BMPR2 | 3.07178252 |
6 | BUB1 | 2.81815039 |
7 | ACVR1B | 2.45262465 |
8 | FLT3 | 2.37804155 |
9 | RIPK4 | 2.21567224 |
10 | MATK | 2.17867700 |
11 | STK16 | 2.08881094 |
12 | NME2 | 2.07224415 |
13 | EIF2AK3 | 2.01331513 |
14 | MST4 | 1.99563163 |
15 | NEK2 | 1.98814141 |
16 | MAP3K12 | 1.97838570 |
17 | SRPK1 | 1.87593299 |
18 | MKNK1 | 1.80789959 |
19 | NEK9 | 1.80543055 |
20 | VRK1 | 1.75347572 |
21 | TSSK6 | 1.72349815 |
22 | RPS6KA4 | 1.70906263 |
23 | PKN2 | 1.67544620 |
24 | PASK | 1.66880429 |
25 | JAK1 | 1.65308668 |
26 | TLK1 | 1.62847858 |
27 | PRPF4B | 1.59711516 |
28 | PLK4 | 1.55163013 |
29 | BCKDK | 1.51315576 |
30 | TGFBR1 | 1.50058954 |
31 | NEK1 | 1.47249829 |
32 | TTK | 1.45642698 |
33 | AURKB | 1.45169415 |
34 | * ATR | 1.43975570 |
35 | MKNK2 | 1.41799569 |
36 | PLK1 | 1.39222780 |
37 | SCYL2 | 1.39131859 |
38 | CDK4 | 1.37704700 |
39 | BLK | 1.37301419 |
40 | SIK3 | 1.35129882 |
41 | CLK1 | 1.35007362 |
42 | CDK8 | 1.30459539 |
43 | IRAK1 | 1.28173209 |
44 | IRAK2 | 1.27607028 |
45 | FGR | 1.26507258 |
46 | BRSK1 | 1.25779417 |
47 | MAP3K14 | 1.24036597 |
48 | CSK | 1.23573144 |
49 | CCNB1 | 1.18864399 |
50 | STK4 | 1.18505025 |
51 | TAOK2 | 1.18003313 |
52 | TBK1 | 1.13989979 |
53 | MAP3K10 | 1.13293985 |
54 | TEC | 1.12589226 |
55 | STK10 | 1.10756175 |
56 | CDK7 | 1.09035931 |
57 | TRIM28 | 1.07191745 |
58 | PLK3 | 1.03497642 |
59 | MAP4K1 | 1.01875443 |
60 | TAF1 | 1.01216298 |
61 | PIM2 | 0.99322466 |
62 | YES1 | 0.99209983 |
63 | KIT | 0.98231649 |
64 | PBK | 0.97352856 |
65 | DYRK3 | 0.97003769 |
66 | NUAK1 | 0.96831727 |
67 | RPS6KB2 | 0.96637237 |
68 | CDK6 | 0.96396847 |
69 | BCR | 0.95754077 |
70 | JAK2 | 0.95662312 |
71 | IKBKB | 0.95537616 |
72 | PDK3 | 0.94348011 |
73 | PDK4 | 0.94348011 |
74 | MAP2K3 | 0.93637150 |
75 | CHEK2 | 0.93329410 |
76 | JAK3 | 0.92878440 |
77 | PIM1 | 0.92346349 |
78 | KDR | 0.92164106 |
79 | EIF2AK2 | 0.89991793 |
80 | NEK6 | 0.87971651 |
81 | TYK2 | 0.86569917 |
82 | MAP3K8 | 0.82503717 |
83 | GRK7 | 0.80804538 |
84 | CHUK | 0.80481717 |
85 | BTK | 0.80191553 |
86 | CHEK1 | 0.77839849 |
87 | IRAK4 | 0.76556803 |
88 | PDK2 | 0.75103053 |
89 | IKBKE | 0.73690694 |
90 | MAP3K13 | 0.73400974 |
91 | RPS6KA5 | 0.73162703 |
92 | MAP3K1 | 0.72344614 |
93 | * ATM | 0.71466831 |
94 | MAP3K6 | 0.70401855 |
95 | TRIB3 | 0.70351279 |
96 | LRRK2 | 0.69748381 |
97 | TRPM7 | 0.68798390 |
98 | CSNK2A1 | 0.68529377 |
99 | FGFR3 | 0.67747943 |
100 | ZAK | 0.66624792 |
101 | LYN | 0.65653605 |
102 | MAP3K2 | 0.64644606 |
103 | STK3 | 0.64593050 |
104 | ZAP70 | 0.63470259 |
105 | ERBB3 | 0.62281003 |
106 | RAF1 | 0.62156733 |
107 | TGFBR2 | 0.62152633 |
108 | KSR1 | 0.61986740 |
109 | MELK | 0.60513290 |
110 | TESK1 | 0.60423763 |
111 | CSNK2A2 | 0.60035382 |
112 | PAK4 | 0.58717216 |
113 | ALK | 0.56243707 |
114 | TESK2 | 0.55755564 |
115 | STK24 | 0.53684751 |
116 | CDK2 | 0.53412458 |
117 | AURKA | 0.53046310 |
118 | FGFR4 | 0.52394810 |
119 | HCK | 0.52211276 |
120 | MARK3 | 0.50867291 |
121 | TXK | 0.50773370 |
122 | CDK12 | 0.50328782 |
123 | MAP3K3 | 0.50266714 |
124 | TTN | 0.50136273 |
125 | MAP3K5 | 0.49519994 |
126 | NLK | 0.49161795 |
127 | MST1R | 0.48541228 |
128 | RIPK1 | 0.45580698 |
129 | MAPKAPK3 | 0.45304241 |
130 | DDR2 | 0.41629111 |
131 | SYK | 0.40445504 |
132 | EEF2K | 0.40191224 |
133 | MOS | 0.39930125 |
134 | CSF1R | 0.39877338 |
135 | RPS6KB1 | 0.38922564 |
136 | PIK3CG | 0.37717587 |
137 | IRAK3 | 0.37710513 |
138 | MAPKAPK2 | 0.36016736 |
139 | CDK1 | 0.35321206 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 5.04980357 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 3.90229312 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.77821315 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.73434300 |
5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.70681370 |
6 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.66715433 |
7 | * Homologous recombination_Homo sapiens_hsa03440 | 2.57857690 |
8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.50976640 |
9 | Spliceosome_Homo sapiens_hsa03040 | 2.44720533 |
10 | Base excision repair_Homo sapiens_hsa03410 | 2.39735751 |
11 | Proteasome_Homo sapiens_hsa03050 | 2.28167174 |
12 | Cell cycle_Homo sapiens_hsa04110 | 2.23112119 |
13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.18913237 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.16711242 |
15 | RNA transport_Homo sapiens_hsa03013 | 2.12574757 |
16 | RNA polymerase_Homo sapiens_hsa03020 | 2.07744048 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94957294 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.92465076 |
19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79932561 |
20 | Malaria_Homo sapiens_hsa05144 | 1.73160290 |
21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71175538 |
22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.71041946 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70065294 |
24 | Tuberculosis_Homo sapiens_hsa05152 | 1.68512173 |
25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68046389 |
26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64950581 |
27 | Asthma_Homo sapiens_hsa05310 | 1.64360653 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61578083 |
29 | RNA degradation_Homo sapiens_hsa03018 | 1.50661040 |
30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49753900 |
31 | Hepatitis C_Homo sapiens_hsa05160 | 1.47001073 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46632954 |
33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40039162 |
34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40002640 |
35 | Protein export_Homo sapiens_hsa03060 | 1.37565205 |
36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36829394 |
37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33585877 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31999423 |
39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30946048 |
40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30801845 |
41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.29511649 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.26891352 |
43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.26300719 |
44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25759509 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24656888 |
46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24230304 |
47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23961955 |
48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17905704 |
49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15908016 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 1.14539490 |
51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13646060 |
52 | Legionellosis_Homo sapiens_hsa05134 | 1.13437631 |
53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11791705 |
54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09385724 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09088347 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09016393 |
57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08895566 |
58 | Purine metabolism_Homo sapiens_hsa00230 | 1.08887979 |
59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06613520 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03190209 |
61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00452479 |
62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00037343 |
63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99664799 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96533060 |
65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96391270 |
66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96017266 |
67 | Bladder cancer_Homo sapiens_hsa05219 | 0.95685384 |
68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93029769 |
69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92427292 |
70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89725075 |
71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89118623 |
72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88574794 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88193112 |
74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84741062 |
75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84634935 |
76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83214729 |
77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82529062 |
78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81018660 |
79 | Lysosome_Homo sapiens_hsa04142 | 0.80975498 |
80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80833607 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80529070 |
82 | Prostate cancer_Homo sapiens_hsa05215 | 0.80036647 |
83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79949456 |
84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78091830 |
85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77209147 |
86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74961026 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74043640 |
88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72079039 |
89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70502603 |
90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.69849992 |
91 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68162875 |
92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67965045 |
93 | Measles_Homo sapiens_hsa05162 | 0.67411448 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67354329 |
95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66394689 |
96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65682079 |
97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64384798 |
98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64367843 |
99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63371754 |
100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62863627 |
101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61933499 |
102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60714532 |
103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58361340 |
104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58072317 |
105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.57960578 |
106 | Phagosome_Homo sapiens_hsa04145 | 0.56385909 |
107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54895699 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54031083 |
109 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53736722 |
110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53317615 |
111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53302238 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52794990 |
113 | Amoebiasis_Homo sapiens_hsa05146 | 0.52541274 |
114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51950703 |
115 | Peroxisome_Homo sapiens_hsa04146 | 0.51844003 |
116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50975112 |
117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50749355 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50616178 |
119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49955213 |
120 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49763551 |
121 | Allograft rejection_Homo sapiens_hsa05330 | 0.48437355 |
122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48239137 |
123 | Apoptosis_Homo sapiens_hsa04210 | 0.48105669 |
124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47810653 |
125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47634118 |
126 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45877258 |
127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45253734 |
128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44540706 |
129 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43640351 |
130 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42776682 |
131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42730795 |
132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42343691 |
133 | Influenza A_Homo sapiens_hsa05164 | 0.42257530 |
134 | Platelet activation_Homo sapiens_hsa04611 | 0.41701773 |
135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40380617 |
136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39413541 |
137 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38749484 |
138 | Hepatitis B_Homo sapiens_hsa05161 | 0.38500673 |
139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38178122 |
140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38032592 |
141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37389537 |
142 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37020659 |
143 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36844090 |
144 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36632360 |
145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36264048 |
146 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35815731 |
147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35750039 |
148 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32757653 |
149 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30994220 |
150 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.30700095 |
151 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29864308 |
152 | Shigellosis_Homo sapiens_hsa05131 | 0.25562695 |
153 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25548937 |
154 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23905671 |